6,317 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by CenterBook Partners LP

CenterBook Partners LP purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 6,317 shares of the company's stock, valued at approximately $433,000.

A number of other hedge funds also recently bought and sold shares of the business. Invesco Ltd. grew its stake in shares of Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after buying an additional 17,552 shares during the last quarter. FMR LLC boosted its stake in Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after purchasing an additional 217,143 shares during the last quarter. Geode Capital Management LLC boosted its stake in Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after purchasing an additional 14,876 shares during the last quarter. Palestra Capital Management LLC purchased a new stake in Henry Schein during the 4th quarter valued at $182,988,000. Finally, Fiduciary Management Inc. WI boosted its stake in Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of HSIC traded down $0.40 during mid-day trading on Friday, hitting $69.10. 1,177,871 shares of the company were exchanged, compared to its average volume of 1,742,763. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. The company has a 50 day moving average of $71.81 and a 200-day moving average of $71.33. The stock has a market cap of $8.41 billion, a price-to-earnings ratio of 21.59, a price-to-earnings-growth ratio of 2.23 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.10 EPS. Analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of recent research reports. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Piper Sandler decreased their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a report on Monday, July 14th. Eight equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $78.36.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.